Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 358

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 358
---
 Feuerstein, a Director of Alpha Capital Anstalt, holds voting and dispositive power over the securities held by Alpha Capital Anstalt. (10)Consists of (i) 189,012 NLS Common Shares, and (ii) 189,012 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of February 27, 2025, subject to a beneficial ownership limitation of 9.99%. Revel Family Ltd. is controlled by Michel Revel, its sole equity owner, who holds voting and dispositive power over the securities. The address of Revel Family Ltd. is 52 HaNasi HaRishon Street, Rehovot, Israel, 7630242. 201

Security Ownership of Certain Beneficial Owners and Management of Kadimastem before the Merger The following tables sets forth information regarding the beneficial ownership of Kadimastem Ordinary Shares as of February27, 2025 by: •each person known by Kadimastem to be the beneficial owner of 5% or more of Kadimastem’s outstanding Ordinary Shares before the consummation of the Merger; •each of its executive officers and directors; •all of its executive officers and directors as a group. Unless otherwise indicated, Kadimastem believes that all persons named in the table will have, immediately before the consummation of the Merger, sole voting and investment power with respect to all Kadimastem’s securities beneficially owned by them. Subject to the paragraph above, percentage ownership of issued shares is based on 4,603,668 Kadimastem Ordinary Shares issued and outstanding on a fully diluted basis as of February27, 2025 (including an outstanding Kadimastem convertible loan that will be converted prior to the Closing).

| Name and Address of Beneficial Owner            |     | NLS Common Shares |     |      |     | Voting 
 Power  
 (%)    |
| Number(1)                                       |     |                 % |     |      |     |        |
| Executive Officers and Directors                |     |                   |     |      |     |        |
| Prof. Michel Revel, MD, PhD and Claire Revel(2) |     |         1,381,958 |     | 28.6 |     |        |
| Ronen Twito(3)                                  |     |           439,832 |     |  9.4 |     |        |
| Oliver Samuel(4